Literature DB >> 9466589

Threshold tracking techniques in the study of human peripheral nerve.

H Bostock1, K Cikurel, D Burke.   

Abstract

Conventional electrophysiological tests of nerve function focus on the number of conducting fibers and their conduction velocity. These tests are sensitive to the integrity of the myelin sheath, but provide little information about the axonal membrane. Threshold tracking techniques, in contrast, test nerve excitability, which depends on the membrane properties of the axons at the site of stimulation. These methods are sensitive to membrane potential, and to changes in membrane potential caused by activation of ion channels and electrogenic ion pumps, including those under the myelin sheath. This review describes the range of threshold tracking techniques that have been developed for the study of human nerves in vivo: resting threshold is compared with the threshold altered by a change in environment (e.g., ischemia), by a preceding single impulse (e.g., refractoriness, superexcitability) or impulse train, or by a subthreshold current (e.g., threshold electrotonus). Few clinical studies have been reported so far, mainly in diabetic neuropathy and motor neuron disease. Threshold measurements seem well suited for studies of metabolic and toxic neuropathies but insensitive to demyelination. Until suitable equipment becomes more widely available, their full potential is unlikely to be realized.

Entities:  

Mesh:

Year:  1998        PMID: 9466589     DOI: 10.1002/(sici)1097-4598(199802)21:2<137::aid-mus1>3.0.co;2-c

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  104 in total

1.  Changes in excitability indices of cutaneous afferents produced by ischaemia in human subjects.

Authors:  J Grosskreutz; C Lin; I Mogyoros; D Burke
Journal:  J Physiol       Date:  1999-07-01       Impact factor: 5.182

2.  Voluntary contraction impairs the refractory period of transmission in healthy human axons.

Authors:  S Kuwabara; C S Lin; I Mogyoros; C Cappelen-Smith; D Burke
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

3.  Differences in accommodative properties of median and peroneal motor axons.

Authors:  S Kuwabara; C Cappelen-Smith; C S Lin; I Mogyoros; D Burke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

4.  Accommodation to depolarizing and hyperpolarizing currents in cutaneous afferents of the human median and sural nerves.

Authors:  C S Lin; I Mogyoros; S Kuwabara; C Cappelen-Smith; D Burke
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

5.  Sodium channel function and the excitability of human cutaneous afferents during ischaemia.

Authors:  Cindy S-Y Lin; Julian Grosskreutz; David Burke
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

6.  Excitability of human muscle afferents studied using threshold tracking of the H reflex.

Authors:  Cindy S-Y Lin; Jane H L Chan; Emmanuel Pierrot-Deseilligny; David Burke
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

7.  Separated interface nerve electrode prevents direct current induced nerve damage.

Authors:  D Michael Ackermann; Niloy Bhadra; Emily L Foldes; Kevin L Kilgore
Journal:  J Neurosci Methods       Date:  2011-01-27       Impact factor: 2.390

8.  Responses of human sensory and motor axons to the release of ischaemia and to hyperpolarizing currents.

Authors:  Cindy S-Y Lin; Satoshi Kuwabara; Cecilia Cappelen-Smith; David Burke
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

9.  Velocity recovery cycles of C fibres innervating human skin.

Authors:  Hugh Bostock; Mario Campero; Jordi Serra; José Ochoa
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

10.  Excitability changes in human peripheral nerve axons in a paradigm mimicking paired-pulse transcranial magnetic stimulation.

Authors:  Jane H L Chan; Cindy S-Y Lin; Emmanuel Pierrot-Deseilligny; David Burke
Journal:  J Physiol       Date:  2002-08-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.